Due to the lack of published data, for comparison, we also studied the effectiveness of a selective activator of Nrf2 (bardoxolone methyl) [39,40] and a selective activator of PI3K (740 Y-P) [41] in CCI-evoked neuropathy. Here, NFE2L2 is linked to neuropathy.